Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, Thomas Meds received an FDA Warning Letter issued on August 26, 2020, regarding drug products. Without access to the full warning letter text or a detailed subject line, the specific nature of the violations cannot be determined from the available information. The letter was issued under FDA's drug regulatory authority, though the specific issuing office is not identified in this metadata. To understand the exact compliance issues and required corrective actions, review of the complete warning letter would be necessary.